Acta Med. 2025, 68: 45-49
https://doi.org/10.14712/18059694.2025.18
Prognostic Impact of Baseline Serum Creatinine in Patients with Advanced High-Grade Serous Ovarian Carcinoma Undergoing Neoadjuvant Chemotherapy
Ivan Práznoveca
, Jiří Špaček, Jr.b, Munachiso Iheme Ndukwea, Denisa Pohankovác, Eva Čermákovác, Igor Sirákc, Jiří Špačeka
, Jiří Špaček, Jr.b, Munachiso Iheme Ndukwea, Denisa Pohankovác, Eva Čermákovác, Igor Sirákc, Jiří Špačeka
aDepartment of Obstetrics and Gynecology, Charles University, Faculty of Medicine in Hradec Králové, University Hospital Hradec Králové, Hradec Králové, Czech Republic
bDepartment of Urology, Charles University, Faculty of Medicine in Hradec Králové, University Hospital Hradec Králové, Hradec Králové, Czech Republic
cDepartment of Oncology and Radiotherapy, Charles University, Faculty of Medicine in Hradec Králové, University Hospital Hradec Králové, Hradec Králové, Czech Republic
Received July 14, 2025
Accepted August 15, 2025
References
1. MS, Bacon M, Tu D, Butler L, Bezjak A, Stuart GC. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecol Oncol. 2008 Jan; 108(1): 100–5.
<https://doi.org/10.1016/j.ygyno.2007.08.088>
2. S, Kim R, Bernardini MQ, et al. Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer. Gynecol Oncol. 2022 Dec; 167(3): 417–22.
<https://doi.org/10.1016/j.ygyno.2022.10.014>
3. C, Nagel D, Glas M, et al. Preoperative serum markers for individual patient prognosis in stage I–III colon cancer. Tumour Biol. 2015 Sep; 36(10): 7897–906.
<https://doi.org/10.1007/s13277-015-3522-z>
4. MK, Boorjian SA, Gettman MT, Rangel LJ, Bergstralh EJ, Karnes RJ. Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical prostatectomy. Urol Oncol. 2013 Nov; 31(8): 1483–8.
<https://doi.org/10.1016/j.urolonc.2012.03.014>
5. M, Moon KC, Choi WS, et al. Prognostic value of systemic inflammatory responses in patients with upper urinary tract urothelial carcinoma. World J Urol. 2015 Oct; 33(10): 1439–57.
<https://doi.org/10.1007/s00345-015-1484-9>
6. RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992 Oct; 38(10): 1933–53.
<https://doi.org/10.1093/clinchem/38.10.1933>
7. JH, Brooks CS, Burch RN. Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis. 1982 Nov; 2(3): 337–46.
<https://doi.org/10.1016/S0272-6386(82)80091-7>
8. AJ, Levey AS. Dietary protein and renal function. J Am Soc Nephrol. 1993 May; 3(11): 1723–37.
<https://doi.org/10.1681/ASN.V3111723>
9. WE, Walser M. A proposed mechanism for reduced creatinine excretion in severe chronic renal failure. Nephron. 1978; 21(5): 248–54.
<https://doi.org/10.1159/000181400>
10. H, Vrydags N, Mahieu B, Vandewynckele E, Croes K, Martens F. Establishing age/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods. Clin Chim Acta 2008 Oct; 396(1–2): 49–55.
<https://doi.org/10.1016/j.cca.2008.06.017>
11. PE, Kapke GF, Leroux JM. Adaptive Bayesian approach to clinical trial renal impairment biomarker signal from urea and creatinine. Int J Biol Sci. 2013; 9(2): 156–63.
<https://doi.org/10.7150/ijbs.5225>
<PubMed>
12. J, Hu J, Liu G, Cui Y, Ju Y. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients. Arch Gynecol Obstet. 2017 Feb; 295(2): 459–65.
<https://doi.org/10.1007/s00404-016-4258-8>
13. Y, Kim HS, Kim M, Lee M, Song YS. Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis. J Gynecol Oncol. 2017 May; 28(3): e36.
<https://doi.org/10.3802/jgo.2017.28.e36>
<PubMed>
14. AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Mori KM, Goldstein BH. The impact of total parenteral nutrition on postoperative recovery in patients treated for advanced stage ovarian cancer. Arch Gynecol Obstet. 2017 Feb; 295(2): 439–44.
<https://doi.org/10.1007/s00404-016-4227-2>
15. M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J. ESMO Guidelines Committee. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018 Oct 1; 29(Suppl 4): iv96–iv110. Erratum in: Ann Oncol. 2018 Oct 1; 29(Suppl 4): iv271.
<https://doi.org/10.1093/annonc/mdx758>
16. M, Copur S, Yildiz AB, Tanriover C, Mallamaci F, Zoccali C. Physical exercise in kidney disease: A commonly undervalued treatment modality. Eur J Clin Invest. 2024 Feb; 54(2): e14105.
<https://doi.org/10.1111/eci.14105>
